MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/17512433.2021.1979394

Медицинская библиотека · Expert review of clinical pharmacology · 2021

Age and psoriatic arthritis are important predictors of biologic agent switch in psoriasis.

Akdogan Neslihan, Dogan Sibel, Bostan Ecem, Gulseren Duygu, Yalici-Armagan Basak, Elcin Gonca, Evans Sibel Ersoy, Karaduman Aysen, Atakan Nilgun

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The demand of biologic switching is increasing for different reasons.We aimed to define reasons for switching biologics and possible predictors for switching risk,and to estimate data on drug survival.

METHODS

115 patients treated with biologics who switched to a second, third,and/or fourth biologic were eligible for this retrospective study.Patients were divided into 2 groups as switched once,and switched twice or more.Drug survival rates were calculated using the Kaplan-Meier method.

RESULTS

All patients switched at least one, 36 patients switched twice, and 9 switched thrice. First-, second-, and third-line biologics were mostly switched due to secondary lack of efficacy for skin disease.Each unit increase in age decreased the risk of having ≥2 switches 4% (p=0.038,OR:0.964,95%CI:0.93-0.998),whereas PsA increased the risk of having ≥2 switches 2.69-fold (p=0.026,OR:2.69,95%CI:1.12-6.44).There was significant difference between biologics in terms of drug survival(p=0.001).Adalimumab had a lower drug survival compared to ustekinumab(p<0.001) and secukinumab(p=0.003) in transition from second-line biologic to third-line biologic.

CONCLUSION

Switching biologics was most commonly due to secondary lack of efficacy for skin disease.Lower ages and the presence of PsA were associated with a higher need for switching in long-term.Ustekinumab and secukinumab are superior to adalimumab in clinical practice in terms of drug survival of second-line biologics.

Для цитирования: Akdogan Neslihan, Dogan Sibel, Bostan Ecem, Gulseren Duygu, Yalici-Armagan Basak, Elcin Gonca, Evans Sibel Ersoy, Karaduman Aysen, Atakan Nilgun. Age and psoriatic arthritis are important predictors of biologic agent switch in psoriasis.. Expert review of clinical pharmacology. 2021. DOI: 10.1080/17512433.2021.1979394.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.